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A 22-year old woman, born in Pakistan and living in the Netherlands since childhood, 
presented with progressive bloody diarrhea, severe abdominal pain and vomiting since one 
month.   
Her medical and family history were negative for (gastrointestinal) diseases. Clinical 
examination revealed an alert woman, without fever or hemodynamic instability. Palpitation 
of the abdomen was painful without signs of rebound tenderness. Mild hyperpigmentation 
was shown on the legs and arms. Her laboratory results:  hemoglobin 10.9 g/dL, C-reactive 
protein 44 mg/L, leukocytes 7.1 x 10^9/L, albumin 1.8 g/dL. Liver enzymes and renal values 
were normal. Fecal and blood cultures remained negative. Alpha-1-antitrypsine was 9,6 mg/g 
fe, compatible with protein losing enteropathy.  
Through colonoscopy we detected multiple polyps seizing almost the complete colonic 
lumen, causing mild luminal stenosis (Figure 1). A mild inflammation was seen in between 
the severe polyposis, with a normal mucosal aspect of the ileum and rectum. Biopsies and 
removal of 1 polyp was performed. Additional abdominal computed tomography revealed 
diffuse wall thickening of colon and appendix, without signs of perforation or toxic 
megacolon. Magnetic Resonance Enteroclysis and gastro duodenoscopy detected no 
abnormalities.   
What is most likely underlying in this young adult? What would be the next step in diagnosis 


























Answer to the Clinical Challenges and Images in GI Question:  
Inflammatory Bowel Disease, with polyposis and protein-losing enteropathy   
Polyposis combined with protein losing enteropathy is most commonly attributed to a 
polyposis syndrome. In this context, the first differential diagnosis included Cronkhite Canada 
syndrome (CCS), Peutz Jeghers Syndrome, Juvenile polyposis, Cowden Syndrome, Familiar 
adenomatous -, MUTH-associated- or CAP-polyposis or Inflammatory Bowel Disease 
(IBD)(1).  
The presentation of this case with bloody diarrhea, protein losing enteropathy, 
hyperpigmentation and polyposis matched with the CCS(2). Pathology of the first biopsies 
and polypectomy showed atypical polyps, without hamartomatous or adenomatous features 
and with mild atypical inflammation. Moreover, a cancer genetic testing panel excluded most 
of the described causes of polyposis. For these reasons, the differential diagnosis remained 
CCS and IBD.   
Treatment was started with Prednisolone, which failed. The next treatment step was anti-
TNF-alpha therapy (Infliximab), which is besides treatment for IBD, also described in case 
reports for the treatment of CCS(2). It showed minimal improvement and clinical progression 
was during two doses. Nutritional status was optimized with total parental nutrition. However, 
the protein-losing enteropathy remained. Despite the treatment, the clinical condition of this 
patient deteriorated and after previous refusal of a colectomy, she accepted surgical 
treatment.  
Subtotal colectomy with ileostomy was performed three months after presentation, which did 
reveal crypt distortion of the entire colon (Figure 2). Polyps were histopathologically 
described as pseudo polyps, with mild inflammation in between and most compatible with 
ulcerative colitis (Figure 3). 
The patient quickly recovered post-surgery. The protein losing enteropathy, abdominal pain 
and bloody stool disappeared, and she gained weight. 
Protein losing enteropathy (PLE) is a rare complication of Inflammatory Bowel Disease, 
which can only appear after exclusion of liver or kidney failure and malnutrition. Alpha-1-
antitrypsine clearance in stool is a rate for PLE(3). In this case, subtotal colectomy was the 
only treatment left because of clinical decline, but in the end proved to be a solution for PLE.  
To conclude, a relatively common disease as Inflammatory Bowel Disease can present with 
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